{"id":110293,"date":"2014-03-26T13:16:19","date_gmt":"2014-03-26T13:16:19","guid":{"rendered":"http:\/\/rinf.com\/alt-news\/?p=110293"},"modified":"2014-03-26T13:16:19","modified_gmt":"2014-03-26T13:16:19","slug":"big-pharma-profiteering-gone-wild","status":"publish","type":"post","link":"http:\/\/rinf.com\/alt-news\/breaking-news\/big-pharma-profiteering-gone-wild\/","title":{"rendered":"Big Pharma profiteering gone wild"},"content":{"rendered":"<p>The financial raping of America by Big Pharma has just achieved a new milestone with the impending launch of a Hepatitis C drug that costs $1,000 a pill. If you\u2019ve ever wondered why U.S. health care is so unaffordable and inaccessible \u2013 and why health insurance costs are bankrupting businesses and municipalities across the nation \u2013 this is exactly why. The same drug that sells for $1,000 a pill in the USA \u2013 named \u201cSovaldi\u201d \u2013 sells for just $10 in Egypt, or 1\/100th the USA price.<\/p>\n<p>Drug companies are, of course, granted\u00a0<b>FDA-enforced monopolies<\/b>\u00a0on the treatment of anything considered a \u201cdisease.\u201d As such, drugs are pushed into the marketplace at monopoly prices. Because if you\u2019re the CEO of Gilead Sciences, Inc., makers of the Sovaldi drug to be sold at $1,000 a pill, your job is to maximize revenues by any means necessary. When you\u2019re handed a monopoly by the FDA, the strategy for achieving that is simple: Raise the price to whatever you can get away with, then bill the insurance companies, Medicare and Medicaid for $100, $500 or even $1,000 a pill.<\/p>\n<p><strong>100,000% mark-up?<\/strong><\/p>\n<p>Even if one pill of Sovaldi only costs 68 cents to manufacture, it will still be sold at $1,000 a pill because that\u2019s what the company demands. At this price, a course of treatment runs $84,000 in the USA. Gilead reduces the price to $57,000 in the UK \u2013 apparently in a completely arbitrary manner based on whatever it can get for the drug rather than the drug\u2019s actual cost or value.<\/p>\n<p>How much does this drug actually cost to produce? Consider this shocking fact, as\u00a0<a href=\"http:\/\/www.cnbc.com\/id\/101515736\">reported by CNBC<\/a>:<\/p>\n<p><i>Gilead confirmed that it had agreed to supply the new drug in Egypt \u2014 which has the world\u2019s highest prevalence of the virus due to use of contaminated needles in the 1970s \u2014 at around $900 for a 12-week course of therapy, or about 1 percent of the U.S. price.<\/i><\/p>\n<p>Yep, the same\u00a0<a href=\"http:\/\/www.naturalnews.com\/drug.html\">drug<\/a>\u00a0sold in the USA for $84,000 is sold in Egypt for $900 \u2013 and the company still makes a profit!<\/p>\n<p>What we are likely looking at with this drug is something approaching a\u00a0<b>100,000% mark-up<\/b>. In any other industry, that would be called \u201cprofiteering.\u201d<\/p>\n<p><a href=\"http:\/\/www.naturalnews.com\/044463_Big_Pharma_profiteering_Sovaldi_overpriced_drugs.html\" target=\"_blank\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The financial raping of America by Big Pharma has just achieved a new milestone with the impending launch of a Hepatitis C drug that costs $1,000 a pill. If you\u2019ve ever wondered why U.S. health care is so unaffordable and inaccessible \u2013 and why health insurance costs are bankrupting businesses and municipalities across the nation [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":107474,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[487],"tags":[],"class_list":{"0":"post-110293","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-breaking-news"},"_links":{"self":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/posts\/110293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/comments?post=110293"}],"version-history":[{"count":0,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/posts\/110293\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/media\/107474"}],"wp:attachment":[{"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/media?parent=110293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/categories?post=110293"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/rinf.com\/alt-news\/wp-json\/wp\/v2\/tags?post=110293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}